Condition: Radiation Pneumonitis · Sponsor: Instituto Nacional de Cancerologia de Mexico
This randomized clinical study aims to assess whether prophylactic treatment with inhaled steroids in patients with locally advanced or concomitantly treated non-small cell lung carcinoma who are candidates for combination treatment with QT/RT or IMT + QT/RT. The main questions it aims to answer are: Whether prophylactic treatment decreases the severity of NPR on CTCAE v4.0 and RTOG scales. Whether inhaled steroid use modifies the response to radiation therapy treatment compared to patients who do not receive prophylactic inhaled steroids.
This description comes directly from the study's public registry record.
Oscar Arrieta, MD MSc · 015556280400 · ogarrieta@gmail.com
Diana Flores · 015556280400 · clinicacancerpulmonincan@gmail.com
Always discuss trial participation with your own doctor first.
| Instituto Nacional de Cancerologia | Mexico City, Mexico | Recruiting |
| Instituto Nacional de Enfermedades Respiratorias | Mexico City, Mexico | Active Not Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03803787